VGLUT2 Transmission in Prefrontal Cortex and Working Memory
前额皮质和工作记忆中的 VGLUT2 传输
基本信息
- 批准号:8700767
- 负责人:
- 金额:$ 21.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdultAttentionBehavioralDevelopmentDisinhibitionEquilibriumExhibitsFeedbackFrequenciesFunctional disorderGlutamatesGoalsHippocampus (Brain)Immunofluorescence ImmunologicImpaired cognitionIn VitroInterneuronsKnockout MiceKnowledgeLeadLearningMeasuresMedialMediatingMemoryMemory impairmentMusN-MethylaspartateNeuronsOutcomeParvalbuminsPatientsPhysiologicalPrefrontal CortexPreventionPrimatesReceptor SignalingRecurrenceReversal LearningRodentRoleSchizophreniaShort-Term MemorySliceSynapsesSynaptic TransmissionSystemTestingTherapeuticTransgenic Miceaspartate receptorbasedevelopmental diseaseendophenotypegamma-Aminobutyric Acidhippocampal pyramidal neuronimprovedin vivoinsightneocorticalpostsynapticpresynapticpreventpublic health relevanceselective expressiontransmission processtreatment strategyvesicular glutamate transporter 2
项目摘要
Abstract. Schizophrenia is a developmental disorder that is hypothesized to include alterations in
glutamatergic function, aberrant N-methyl-D-aspartic acid receptor (NMDAR) signaling and altered
excitatory/inhibitory (E/I) balance in the medial prefrontal cortex (mPFC). A critical barrier to progress in
improving strategies for the treatment and prevention of schizophrenia is a lack of understanding of the role of
presynaptic glutamate release onto GABAergic interneurons by intrinsic cortical vesicular glutamate
transporter-2 (VGLUT2) synapses in regulating E/I balance and how this may impact the maturation of PV-
containing interneurons. Our goal is to improve strategies for the treatment and prevention of schizophrenia by
developing and providing an understanding of the role and influence of VGLUT2-mediated glutamate release
on the dysfunction of the PV-inhibitory system. Our central hypothesis is that VGLUT2 provides glutamate
to neocortical PV+ inhibitory interneurons in the mPFC that is important for the maturation of
excitatory/inhibitory (E/I) balance and to working memory. Our objectives are to (1) establish that functional
VGLUT2 synapses target the PV+ interneuronal system in mPFC in vivo and in vitro, (2) demonstrate that the
loss of VGLUT2 synapses decreases glutamate release at E-I synapses and suppresses inhibitory
transmission, and (3) show that conditional VGLUT2 knockout (KO) mice display deficits in working memory.
Our expected outcomes will be (1) an understanding that intrinsic cortical VGLUT2 synapses are relevant to
E/I balance because they target recurrent inhibitory feedback neurons and exhibit activity-dependent release of
glutamate, (2) the knowledge that loss of intrinsic cortical VGLUT2 expression in conditional VGLUT2 KO mice
leads to a reduction in GAD67 in PV+ interneurons and suppresses inhibitory synaptic transmission onto
pyramidal neurons, and (3) to affirm that VGLUT2-encoded transmission in corticolimbic circuits is critical to
working memory. The impact of these results on strategies for treating and preventing schizophrenia that our
outcomes will provide is an important step towards therapeutic insight into the cognitive impairment associated
with schizophrenia and an understanding of the role and influence of VGLUT2-mediated release on the
maturation of the PV-interneuronal system and E/I balance. Aim 1 will test the hypothesis that intrinsic cortical
VGLUT2 synapses are relevant to E/I balance because a) they target PV+ GABAergic interneurons, b) they
exhibit activity-dependent release of glutamate, and c) their loss suppresses inhibitory synaptic transmission in
the mPFC. We will utilize GAD67gfp+ transgenic mice that selectively express EGFP in PV+ interneurons for
immunofluorescence and electrophysiologic studies. Aim 2 will test the hypothesis that VGLUT2-encoded
excitatory transmission in corticolimbic circuits during development is critical to working memory in adults, by
assessing working memory function using the continuous delayed alternation task in a T-maze in two lines of
mice where VGLUT2 inactivation occurs early in development and in adolescent mice.
抽象的。精神分裂症是一种发展障碍,假设包括改变
谷氨酸能函数,异常N-甲基-D-天冬氨酸受体(NMDAR)信号传导
内侧前额叶皮层(MPFC)中的兴奋性/抑制(E/I)平衡。进步的关键障碍
改善治疗和预防精神分裂症的策略是缺乏了解的作用
内在皮质囊泡谷氨酸到GABA能中间神经元的突触前谷氨酸释放
转运蛋白2(VGLUT2)在调节E/I平衡方面的突触以及这可能会影响PV-的成熟
包含中间神经元。我们的目标是通过通过
发展并提供对VGLUT2介导的谷氨酸释放的作用和影响的理解
在PV抑制系统的功能障碍上。我们的中心假设是VGLUT2提供谷氨酸
对于MPFC中的新皮质PV+抑制性中间神经元,这对于成熟很重要
兴奋/抑制(E/I)平衡和工作记忆。我们的目标是(1)确定该功能
VGLUT2突触针对MPFC的PV+体内和体外中的PV+中间系统,(2)证明了该系统
vglut2突触的损失可在E-I突触下降低谷氨酸释放并抑制抑制作用
传输,(3)显示有条件的VGLUT2敲除(KO)小鼠在工作记忆中显示缺陷。
我们的预期结果将是(1)理解,内在的皮质VGLUT2突触与
e/i平衡是因为它们靶向复发性抑制反馈神经元,并表现出活动依赖性释放
谷氨酸,(2)有条件vglut2 ko小鼠中内在皮质vglut2表达的丧失的知识
导致PV+中间神经元中的GAD67降低,并抑制抑制性突触传播
锥体神经元和(3)确认Corticolimbic电路中VGLUT2编码的传播对
工作记忆。这些结果对治疗和预防精神分裂症的策略的影响
结果将提供是迈向治疗洞察力的重要一步
有精神分裂症以及对VGLUT2介导的释放对该的作用和影响的理解
PV interneronal系统和E/I平衡的成熟。 AIM 1将测试内在皮质的假设
VGLUT2突触与E/I平衡有关,因为A)它们针对PV+ GABA能中间神经元,b)它们
表现出活性依赖性谷氨酸的释放,c)它们的损失抑制了抑制性突触传播
MPFC。我们将利用GAD67GFP+转基因小鼠,在PV+ INTERRONS中有选择地表达EGFP
免疫荧光和电生理研究。 AIM 2将测试vglut2编码的假设
开发过程中皮质降虫电路中的兴奋性传播对于成年人的工作记忆至关重要,
使用连续延迟交替任务在T迷宫中评估工作记忆函数
vglut2失活的小鼠在发育早期和青少年小鼠中发生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY D ERICKSON其他文献
JEFFREY D ERICKSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY D ERICKSON', 18)}}的其他基金
Novel Riluzole Derivatives for Alzheimer's Disease
治疗阿尔茨海默病的新型利鲁唑衍生物
- 批准号:
9979211 - 财政年份:2020
- 资助金额:
$ 21.89万 - 项目类别:
Novel presynaptic agents to prevent glutamate-induced neural injury
预防谷氨酸引起的神经损伤的新型突触前药物
- 批准号:
10530621 - 财政年份:2019
- 资助金额:
$ 21.89万 - 项目类别:
Novel presynaptic agents to prevent glutamate-induced neural injury
预防谷氨酸引起的神经损伤的新型突触前药物
- 批准号:
10058292 - 财政年份:2019
- 资助金额:
$ 21.89万 - 项目类别:
Neuronal Activity-Regulated Glutamine Transporter
神经元活动调节的谷氨酰胺转运蛋白
- 批准号:
9888453 - 财政年份:2019
- 资助金额:
$ 21.89万 - 项目类别:
Novel presynaptic agents to prevent glutamate-induced neural injury
预防谷氨酸引起的神经损伤的新型突触前药物
- 批准号:
10308022 - 财政年份:2019
- 资助金额:
$ 21.89万 - 项目类别:
VGLUT2 Transmission in Prefrontal Cortex and Working Memory
前额皮质和工作记忆中的 VGLUT2 传输
- 批准号:
8842715 - 财政年份:2014
- 资助金额:
$ 21.89万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of tACS on alcohol-induced cognitive and neurochemical deficits
tACS 对酒精引起的认知和神经化学缺陷的影响
- 批准号:
10825849 - 财政年份:2024
- 资助金额:
$ 21.89万 - 项目类别:
Implementing SafeCare Kenya to Reduce Noncommunicable Disease Burden: Building Community Health Workers' Capacity to Support Parents with Young Children
实施 SafeCare Kenya 以减少非传染性疾病负担:建设社区卫生工作者支持有幼儿的父母的能力
- 批准号:
10672785 - 财政年份:2023
- 资助金额:
$ 21.89万 - 项目类别:
Screening and Brief Intervention for Prescription Stimulant Misuse and Diversion: Refining and Piloting a Curriculum for College Health Providers
针对处方兴奋剂滥用和转移的筛查和简短干预:为大学医疗服务提供者完善和试点课程
- 批准号:
10731122 - 财政年份:2023
- 资助金额:
$ 21.89万 - 项目类别:
Thalamo-prefrontal circuit maturation during adolescence
丘脑-前额叶回路在青春期成熟
- 批准号:
10585031 - 财政年份:2023
- 资助金额:
$ 21.89万 - 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
- 批准号:
10575222 - 财政年份:2023
- 资助金额:
$ 21.89万 - 项目类别: